Skip to content

Parent Educational Discharge Support Strategies

Nurse-Led Parent Educational Discharge Support Strategies (PEDSS) for Children Newly Diagnosed With Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03227068
Enrollment
289
Registered
2017-07-24
Start date
2017-12-29
Completion date
2020-06-29
Last updated
2020-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Educational Activities

Keywords

pediatric oncology, parent

Brief summary

After the initial hospitalization, parents of children newly diagnosed with cancer assume responsibility for assessing and managing their care; however, parents are often overwhelmed with information received throughout the hospitalization and are apprehensive about caring for their child at home. Parents want concise, focused information on how to care for their child after the hospital discharge. Two parent education discharge support strategies (PEDSS) were created to use at hospital discharge. PEDSS consists of a symptom management intervention and a support for the caregiver intervention. A cluster randomized control trial will assess the effectiveness and feasibility of the two different interventions.

Detailed description

Providing education to parents of children newly diagnosed with cancer is a primary component of nursing practice, but best practices regarding delivery of information are not known. Parents often report confusion and worry with the complexity and large volume of information received during the initial hospitalization that leads to concerns in caring for their child after discharge. In addition, the amount and content of education is not standardized across institutions. This results in considerable variability in educational practices, including symptom education. During a recent qualitative study, parents described helpful discharge education strategies as having written materials, keeping information concise, and receiving anticipatory guidance so they knew what to expect. These preferences were succinctly summarized by a mother of a child newly diagnosed with leukemia who stated …it would be nice to have one sheet of paper that just said 'these are the signs that you're looking for at home'. The purpose of this research study is to implement and evaluate parent educational discharge support strategies (PEDSS) for parents of children newly diagnosed with cancer. Findings from this study will provide a framework for nurses to deliver concise and consistent information to parents of children newly diagnosed with cancer, and will assist parents with their child after hospital discharge. The goal of this study is to determine the effectiveness and feasibility of two parent education discharge support strategies (PEDSS - symptom management vs. PEDSS - support for the caregiver) for parents of children newly diagnosed with cancer. Specific aims of the study include: Specific Aim 1: Explore the effects of parent education discharge support strategies on childhood cancer symptoms (fever, pain, fatigue, nausea, appetite changes, and sleep problems) and parents' perception of their ability to care for their child with a new cancer diagnosis during the first two months following the initial hospital discharge. Specific Aim 2: Determine whether implementation of parent education discharge support strategies decreases unplanned utilization of healthcare services (unscheduled clinic visits, emergency room visits, unplanned hospitalizations), and preventable toxicity (malnutrition, sepsis) among children with cancer during the first two months following the initial hospitalization. Specific Aim 3: Examine the feasibility and fidelity of implementing the PEDSS at the initial hospital discharge among parents of newly diagnosed children with cancer for use through the first two months following hospital discharge at participating Magnet institutions.

Interventions

OTHERPEDSS - symptom management

All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - symptom management will be delivered prior to the initial hospital discharge. The nurse will review the symptom management worksheet verbally with the parent, then distribute the written worksheet to the parent.

OTHERPEDSS - support for the caregiver

All subjects will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge, which includes a list of home medications and information regarding whom to call for emergencies. The PEDSS - support for the caregiver will be delivered prior to the initial hospital discharge. The nurse will review the worksheet verbally with the parent, then distribute the written worksheet to the parent.

Sponsors

Children's Health System of Texas Children's Medical Center
CollaboratorUNKNOWN
Cohen Children's Medical Center
CollaboratorOTHER
Levine Children's Hospital
CollaboratorOTHER
Lurie Children's Hospital of Chicago
CollaboratorUNKNOWN
Maine Children's Cancer Program at Maine Medical Center
CollaboratorUNKNOWN
Medical University of South Carolina Children's Hospital
CollaboratorUNKNOWN
Nationwide Children's Hospital
CollaboratorOTHER
Northwestern Medicine Central DuPage Hospital
CollaboratorUNKNOWN
St. Jude Children's Research Hospital
CollaboratorOTHER
St. Louis Children's Hospital
CollaboratorOTHER
St. Peter's University Hospital
CollaboratorUNKNOWN
University of Wisconsin Health American Children's Hospital
CollaboratorUNKNOWN
West Virginia Univeristy Medicine
CollaboratorUNKNOWN
King Faisal Specialist Hospital & Research Center
CollaboratorOTHER
Nicklaus Children's Hospital
CollaboratorUNKNOWN
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

All subjects in both groups will receive education regarding their specific disease and treatment in accordance with current practices. Cancer care providers describe detailed side effects of treatment to parents during the treatment consent process. In addition, all parents will receive standard discharge education before hospital discharge including a list of home medications, and information regarding whom to call for emergencies. The PEDSS - symptom management and PEDSS - support for the caregiver are additional tools designed to reinforce care after the initial hospital discharge.

Eligibility

Sex/Gender
ALL
Age
3 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* A parent (referred to as parent but includes a parent or legal guardian) of a patient 3 to 17 years of age who is newly diagnosed with any type of malignant disease on an inpatient oncology unit * Must speak English, Spanish, or Arabic * Child will be or is receiving chemotherapy and/or radiation therapy

Exclusion criteria

* A parent of a child diagnosed with histiocytosis or any hematological disease considered non-malignant * A parent whose child received the initial cancer diagnosis and initial cancer treatment while hospitalized on a non-oncology unit (i.e., surgical ward) * A parent of a child who is experienced a relapse of a malignant disease * A parent who is the primary caregiver of the child with cancer and is illiterate

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline pain behavior to two monthsAt baseline and monthly for two additional monthsPROMIS® Pediatric - Pain Behavior Short Form
Change from baseline pain severity to two monthsAt baseline and monthly for two additional monthsWong-Baker Faces Scale
Change from baseline nausea severity to two monthsAt baseline and monthly for two additional monthsVisual Analogue Scale in the form of a thermometer that rates the severity of nausea from 0-100
Change from baseline appetite changes to two monthsAt baseline and monthly for two additional monthsSimplified Nutritional Appetite Questionnaire, 4-item asking about child's appetite and rated on a 5-point Likert Scale
Change from baseline fatigue severity to two monthsAt baseline and monthly for two additional monthsCategorized as none to mild or moderate to severe from the Adolescent Fatigue Scale for adolescents 13-17 years of age, the Childhood Fatigue Scale for children 7-12 years of age, or the Parent Fatigue Scale to obtain proxy responses from parents of children \< 7 years of age
Change from baseline sleep disturbances to two monthsAt baseline and monthly for two additional monthsThe Sleep Wake Scale

Secondary

MeasureTime frameDescription
SepsisAt one and two months from start of studyFrequency of septic events over the past month
Change in baseline nutritional status to two monthsAt baseline and monthly for two additional monthsBody mass index
Change of baseline parents' perception of their ability to care for their child with a new cancer diagnosis to two monthsAt baseline and monthly for two additional monthsSeven items asking the parent to rate perceptions of the care of their child's symptoms on a 5-point Likert scale
Unplanned utilization of healthcare servicesAt one and two months from start of studyCombined frequency of the number of unscheduled clinic visits, emergency room visits, and unplanned hospitalizations
PEDSS intervention feasibilityAt baselineNurse documentation of completion of PEDSS discussion and distribution of PEDSS worksheet
PEDSS intervention satisfactionAt two months after intervention deliveryDescriptive items asking about timing of intervention and frequency of intervention use then 6 items scored on a 5-point Likert scale asking about ease of use and satisfaction.

Countries

Saudi Arabia, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026